Zacks Small Cap Research – TWI: Titan International Free Cash Flow Generation Over the Long Term Supports Price Target of $16.00 – Go Health Pro

By Thomas Kerr, CFA NYSE:TWI READ THE FULL TWI RESEARCH REPORT 3rd Quarter 2024 Financial and Operating Results Titan International (NYSE:TWI) reported 3rd quarter 2024 financial results which continued to reflect a difficult macro environment in most of its end markets as the OEM destocking story continues to evolve. Net sales for the 3rd quarter … Read more

BGL Supports National Disability Employment Awareness Month – Go Health Pro

BGL Supports National Disability Employment Awareness Month – Go Health Pro

Brown, Goldstein & Levy is proud to support the 2024 National Disability Employment Awareness Month (NDEAM) this October. The theme for NDEAM 2024, “Access to Good Jobs for All,” celebrates the value and talent workers with disabilities add to America’s workplaces and economy. NDEAM’s purpose is to confirm our commitment to ensuring disabled workers have … Read more

BGL proudly supports National Disability Employment Awareness Month this October, in line with our mission of ensuring individuals with disabilities have access to equitable opportunities in employment. – Go Health Pro

BGL Supports National Disability Employment Awareness Month – Go Health Pro

Brown, Goldstein & Levy is proud to support the 2024 National Disability Employment Awareness Month (NDEAM) this October. The theme for NDEAM 2024, “Access to Good Jobs for All,” celebrates the value and talent workers with disabilities add to America’s workplaces and economy. NDEAM’s purpose is to confirm our commitment to ensuring disabled workers have … Read more

Zacks Small Cap Analysis – CTSO: CytoSorbents Potential for Excessive Margin Income Progress Helps Worth Goal of $4.00 – Go Well being Professional

By Thomas Kerr, CFA NASDAQ:CTSO READ THE FULL CTSO RESEARCH REPORT CytoSorbents (NASDAQ:CTSO) reported 2nd quarter 2024 outcomes on August thirteenth and the outcomes have been principally above our expectations. For the 2nd quarter of 2024, complete revenues elevated roughly 5.0% to $9.9 million. Complete product gross sales have been $8.8 million, a rise of … Read more

x